GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Shandong Jincheng Pharmaceutical Group Co 300233.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

11.58

-0.77%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Shandong Jincheng Pharmaceutical Group Co

Its shares trade on Shenzhen under the ticker 300233.SZ. It has been listed since 22 June 2011. In the fiscal year to 31 December 2025, it reported revenue of CN¥2.74bn and net income of CN¥44.2m. At that date it held total assets of CN¥5.19bn and shareholders' equity of CN¥3.66bn.

Shandong Jincheng Pharmaceutical Group Co., Ltd. engages in the research and development, production and sale of III and IV cephalosporin intermediates and bio-pharmaceuticals. The company is headquartered in Zibo, Shandong. The company went IPO on 2011-06-22. The firm mainly provides active ester side chain of cephalosporin products, other pharmaceutical chemical products, as well as bio-pharmaceuticals and specialty active pharmaceutical ingredient (API). The firm distributes its products within domestic market and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
22 Jun 2011
Employees
3,400

Leadership

Pay as last reported

  • Mr. Yeqing ZhaoChairman of the BoardCN¥1.7m
  • Mr. Jiaquan LiPresident, Vice Chairman of the Board, since 2008CN¥1.6m
  • Ms. Jing LiuChief Financial Officer
  • Mr. Gengxiu ZhengChief Scientific Officer, since 2008CN¥1.2m
  • Mr. Xiaogang ZhuVice President, Secretary of the Board, since 2021CN¥892,400
  • Mr. Hui WangVice President, Director, since 2024
  • Mr. Zhongzheng ZhangVice President, Director, since 2023
  • Mr. Xili CuiVice President, since 2023CN¥1.1m
  • Mr. Xicheng ZhangVice President
  • Mr. Qinyuan MaDirector
  • Mr. Qixiao CaiIndependent DirectorCN¥71,400
  • Mr. Fuli LiIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.